| Hospicio Divino Salvador, Inc Road 2, Km 40, Plaza Jardines, Vega Baja, PR, 00694 | |
| (787) 855-0411 |
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| Name | Hospicio Divino Salvador, Inc |
|---|---|
| Location | Road 2, Km 40, Plaza Jardines, Vega Baja, Puerto Rico |
| Hospice ID | 401562 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 730 |
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| NPI Number | 1699734707 |
| Organization Name | Hospicio Divino Salvador, Inc. |
| Address | Carr. 2 Km. 40.2 Plaza Jardines Vega Baja, Puerto Rico, 00693 |
| Phone Number | (787)855-0411 |
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.4 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 47.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 94.0 | 93.3 |
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| Home Health Aides | 2.5 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 2.5 |
| Medical Social Workers | 1 |
| Registered Nurses | 10 |
| Other Personnel | 4 |
| Total Employees | 21 |
|---|
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| Registered Nurses | 1 |
| Others | 2 |
| Total Volunteers | 3 |
|---|
News Archive
Blue Cross and Blue Shield of Georgia and OneSight®, a Luxottica Group Foundation have teamed to bring a regional clinic to Georgia from today, Monday, March 22, through Friday, March 26. Clayton County, Henry County and Spalding County Schools pre-selected approximately 600 students from kindergarten through high school based on their financial and vision needs to receive free vision care, including full vision exams and new eyewear.
The health implications of polluting the environment weigh increasingly on our public consciousness, and pharmaceutical wastes continue to be a main culprit. Now a Tel Aviv University researcher says that current testing for these dangerous contaminants isn't going far enough.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.
The only acute treatment for a stroke currently available is thrombolysis. This uses drugs that dissolve the blood clot responsible for the stroke, but it only reaches around 10 per cent of stroke patients in time to prevent lasting damage. For other patients, there are no other effective drugs that reduce the loss of brain function following a stroke.
› Verified 1 days ago
| Hospicio Divino Salvador, Inc Location: Road 2, Km 40, Plaza Jardines, Vega Baja, Puerto Rico, 00694 Phone: (787) 855-0411 |